376646-62-7

Basic information

• Product Name: 4-BROMO-2-METHYLBENZYLAMINE
• Synonyms: 4-BROMO-2-METHYLBENZYLAMINE;RARECHEM AL BW 0436;(4-BroMo-2-Methylphenyl)MethanaMine;1-(4-bromo-2-methylphenyl)methanamine;4-Bromo-2-methylbenzenemethanamine;(4-Bromo-2-methylphenyl);Benzenemethanamine, 4-bromo-2-methyl-
• CAS NO: 376646-62-7
• Molecular Formula: C₈H₁₀BrN
• Molecular Weight: 200.08
• Product Categories: Anilines, Aromatic Amines and Nitro Compounds
• Mol File: 376646-62-7.mol

Chemical Properties

• Boiling Point: 270.9°Cat760mmHg
• Flash Point: 117.6°C
• Appearance: /
• Density: 1.41g/cm³
• Vapor Pressure: 0.00666mmHg at 25°C
• Refractive Index: 1.58
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 9.03±0.10(Predicted)
• Sensitive: Air Sensitive
• CAS DataBase Reference: 4-BROMO-2-METHYLBENZYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-2-METHYLBENZYLAMINE(376646-62-7)
• EPA Substance Registry System: 4-BROMO-2-METHYLBENZYLAMINE(376646-62-7)

Safety Data

• Hazard Codes: T
• Hazardous Substances Data: 376646-62-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-BROMO-2-METHYLBENZYLAMINE is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of various medicinal compounds.
Used in Agrochemical Industry:
4-BROMO-2-METHYLBENZYLAMINE is utilized as an intermediate in the production of agrochemicals, playing a role in the creation of substances that aid in crop protection and enhancement.
Used as a Reagent:
In the chemical industry, 4-BROMO-2-METHYLBENZYLAMINE is used as a reagent in the preparation of various compounds, highlighting its versatility in chemical synthesis processes.

InChI:InChI=1/C8H10BrN/c1-6-4-8(9)3-2-7(6)5-10/h2-4H,5,10H2,1H3

Upstream product

• 67832-11-5 4-bromo-2-methylbenzonitrile 

Relevant articles and documents

3-[(1H-PYRAZOL-4-YL)OXY]PYRAZIN-2-AMINE COMPOUNDS AS HPK1 INHIBITOR AND USE THEREOF

Disclosed herein is 3- [ (1H-pyrazol-4-yl) oxy] pyrazin-2-amine compounds of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of modulating, e.g., inhibiting or treating HPK1 related disorders or diseases including cancer by using the compound disclosed herein

COMPOUNDS USEFUL IN INHIBITING DIACYLGLYCEROL O-ACYLTRANSFERASE AND METHODS OF MAKING AND USING THE SAME

Described herein are compounds that may act as an inhibitor of diacylglycerol O- acyltransferase 2 (DGAT2) and/or that may be useful in the treatment of diseases and/or disorders associated with DGAT2. Compositions including such compounds are also described herein along with methods of preparation and use of such compounds and/or compositions.

Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases

Autoreactive B cell-derived antibodies form immune complexes that likely play a pathogenic role in autoimmune diseases. In systemic lupus erythematosus (SLE), these antibodies bind Fc receptors on myeloid cells and induce proinflammatory cytokine producti

INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.

INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, methods for use as Bruton's tyrosine kinase and methods of production.

PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER

This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of t

ADIPATE FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

SUBSTITUTED QUINOLONES

The invention relates to substituted quinolones methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular, for use as antiviral agents, in particular, against cytomegaloviruses.